Willy A. Noort

3.5k total citations · 1 hit paper
46 papers, 2.6k citations indexed

About

Willy A. Noort is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Willy A. Noort has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 17 papers in Genetics and 12 papers in Oncology. Recurrent topics in Willy A. Noort's work include Mesenchymal stem cell research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Neonatal Respiratory Health Research (7 papers). Willy A. Noort is often cited by papers focused on Mesenchymal stem cell research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Neonatal Respiratory Health Research (7 papers). Willy A. Noort collaborates with scholars based in Netherlands, United States and Denmark. Willy A. Noort's co-authors include Willem E. Fibbe, Humphrey H.H. Kanhai, Sicco A. Scherjon, R. Willemze, Frans H.J. Claas, Anton C. Martens, Alwine B. Kruisselbrink, Roel Willemze, Richard W.J. Groen and JH Falkenburg and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Willy A. Noort

45 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

2003 590 citations Sicco A. Scherjon, Willy A. Noort et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Willy A. Noort Netherlands	22	1.2k	933	802	744	586	46	2.6k
Davide Soligo Italy	24	1.1k 0.9×	866 0.9×	753 0.9×	492 0.7×	508 0.9×	72	2.6k
Ted J. Hofmann United States	20	1.6k 1.3×	1.1k 1.2×	462 0.6×	736 1.0×	591 1.0×	34	3.0k
Alessia Funari Italy	12	1.4k 1.1×	827 0.9×	537 0.7×	538 0.7×	593 1.0×	12	2.4k
Marco Milanesi Italy	16	2.3k 1.8×	823 0.9×	533 0.7×	901 1.2×	510 0.9×	31	3.1k
Paolo Longoni Italy	18	2.3k 1.8×	794 0.9×	574 0.7×	919 1.2×	498 0.8×	31	3.2k
Enrique J. Andreu Spain	26	1.1k 0.9×	896 1.0×	532 0.7×	474 0.6×	398 0.7×	46	2.4k
Stefano Ferrari Italy	16	1.6k 1.3×	1.7k 1.8×	522 0.7×	865 1.2×	522 0.9×	32	3.5k
Frederik Wein Germany	14	1.5k 1.2×	620 0.7×	449 0.6×	622 0.8×	396 0.7×	20	2.1k
Paola Matteucci Italy	18	2.4k 1.9×	757 0.8×	537 0.7×	921 1.2×	887 1.5×	39	3.6k
Karen Ferrer United States	18	1.9k 1.6×	687 0.7×	345 0.4×	1.0k 1.4×	424 0.7×	31	3.1k

Countries citing papers authored by Willy A. Noort

Since Specialization

Citations

This map shows the geographic impact of Willy A. Noort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willy A. Noort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willy A. Noort more than expected).

Fields of papers citing papers by Willy A. Noort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willy A. Noort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willy A. Noort. The network helps show where Willy A. Noort may publish in the future.

Co-authorship network of co-authors of Willy A. Noort

This figure shows the co-authorship network connecting the top 25 collaborators of Willy A. Noort. A scholar is included among the top collaborators of Willy A. Noort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willy A. Noort. Willy A. Noort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feyen, Dries, F. van den Akker, Willy A. Noort, et al.. (2016). Isolation of Pig Bone Marrow-Derived Mesenchymal Stem Cells. Methods in molecular biology. 1416. 225–232. 9 indexed citations

Drent, Esther, Richard W.J. Groen, Willy A. Noort, et al.. (2016). Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma. Haematologica. 101(5). 616–625. 141 indexed citations

Nijhof, Inger S., Richard W.J. Groen, H M Lokhorst, et al.. (2015). Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab. Leukemia. 29(10). 2039–2049. 203 indexed citations

Sarkar, Subhashis, Michel van Gelder, Willy A. Noort, et al.. (2015). Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A. Cancer Immunology Immunotherapy. 64(8). 951–963. 46 indexed citations

Feyen, Dries, Roberto Gaetani, Jia Liu, et al.. (2013). Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function. Cardiovascular Research. 99(1). 83–91. 16 indexed citations

Noort, Willy A., Marish I.F.J. Oerlemans, Henk Rozemuller, et al.. (2011). Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. Journal of Cellular and Molecular Medicine. 16(8). 1827–1839. 80 indexed citations

Vrijsen, Krijn R., Joost P. G. Sluijter, Bas W. M. van Balkom, et al.. (2010). Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. Journal of Cellular and Molecular Medicine. 14(5). no–no. 197 indexed citations

Maijenburg, Marijke W., Willy A. Noort, Marion Kleijer, et al.. (2009). Cell cycle and tissue of origin contribute to the migratory behaviour of human fetal and adult mesenchymal stromal cells. British Journal of Haematology. 148(3). 428–440. 27 indexed citations

Hirsch, Alexander, Ingrid Lommerse, Jaap Jan Zwaginga, et al.. (2008). Recovery and functional activity of mononuclear bone marrow and peripheral blood cells after different cell isolation protocols used in clinical trials for cell therapy after acute myocardial infarction. EuroIntervention. 4(1). 133–138. 24 indexed citations

10.

Nauta, Alma J., Alwine B. Kruisselbrink, Ellie G.A. Lurvink, et al.. (2005). Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Experimental Hematology. 33(10). 1249–1256. 18 indexed citations

11.

Fibbe, Willem E. & Willy A. Noort. (2003). Mesenchymal Stem Cells and Hematopoietic Stem Cell Transplantation. Annals of the New York Academy of Sciences. 996(1). 235–244. 68 indexed citations

12.

Noort, Willy A., Alwine B. Kruisselbrink, Sicco A. Scherjon, et al.. (2003). Nonexpanded primary lung and bone marrow–derived mesenchymal cells promote the engraftment of umbilical cord blood–derived CD34+ cells in NOD/SCID mice. Experimental Hematology. 31(10). 881–889. 120 indexed citations

13.

Noort, Willy A., Alwine B. Kruisselbrink, Rutger L. van Bezooijen, et al.. (2002). Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice. Experimental Hematology. 30(8). 870–878. 396 indexed citations

14.

Knulst, André C., et al.. (1994). Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.. PubMed. 13(3). 293–301. 7 indexed citations

15.

Smelt, A.H.M., A. Edo Meinders, Klaas Hoekman, Willy A. Noort, & Marc J.N.C. Keirse. (1992). Secretory diarrhea in villous adenoma of rectum: Effect of treatment with somatostatin and indomethacin. Prostaglandins. 43(6). 567–572. 26 indexed citations

16.

Quartero, H.W.P., Willy A. Noort, Christopher Fry, & Marc J. N. C. Keirse. (1991). Role of prostaglandins and leukotrienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRH) on the contraction force in human gestational myometrium. Prostaglandins. 42(2). 137–150. 44 indexed citations

17.

Noort, Willy A. & Marc J. N. C. Keirse. (1990). Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and labor. European Journal of Obstetrics & Gynecology and Reproductive Biology. 35(1). 15–21. 15 indexed citations

18.

Noort, Willy A., et al.. (1988). Changes in urinary 6-keto-prostaglandin F1α excretion during pregnancy and labor. Prostaglandins. 35(4). 573–582. 11 indexed citations

19.

Noort, Willy A., et al.. (1987). Increase in urinary thromboxane excretion during pregnancy and labor. Prostaglandins. 34(3). 413–421. 15 indexed citations

20.

Noort, Willy A. & J. Egberts. (1984). The composition of fetal rat lung surfactant and the change in fetal plasma inositol concentration. European Journal of Obstetrics & Gynecology and Reproductive Biology. 18(4). 234–234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact